BIO’s Intellectual Property Counsel Committee is holding its Fall Conference and Committee Meeting on Oct. 26-28, 2009, at the St. Regis Hotel in Washington, DC.
BIO’s semi-annual IP Counsels’ Committee Conference is an excellent opportunity for BIO members to hear, listen, and learn about current and projected topics related to biotechnology IP.
I’ll be in attendance as BIO has graciously agreed to allow me to participate and blog about the conference. Look for updates next week. If you’d like to meet up during the conference, drop me a note and we’ll schedule some time to have coffee together. 
Among topics to be discussed:
- US Patent and Trademark Office Updates: Stay abreast of recent developments, rulemakings, and initiatives in the USPTO.
- Implications of recent case law: Join us for our ever-popular case law update! Cases to include Billski and Kubin.
- Updates on patents and IP around the world: Learn about recent developments in major foreign jurisdictions and international forums.
- IP licensing and other contractual agreements: Colleagues will share their experience on best practices and challenges.
- Product by process: US vs. Europe.
- Explore patent issues with proposed biosimilars legislation.
Key highlights include:
- IP Counsels Committee Business Retreat – This is a day-long meeting where we will discuss cutting-edge IP issues affecting the biotech industry. During this time we develop policies and positions for BIO’s Board of Directors to review. The Business meeting is open to BIO IPCC company members only.
- Meet & Greet Welcome Reception at the US Court of Appeals – Meet new colleagues and reconnect with old ones.
- Exclusive tour and dinner at DC’s famous International Spy Museum.
- Distinguished speakers and panelists will review and discuss current issues in biotechnology.
I hope to see you there. More information is available at the IPCC Conference website here.
